作者: Christoph Springfeld , Christiane Wiecha , Romy Kunzmann , Ulrike Heger , Wilko Weichert
DOI: 10.1245/S10434-015-4617-X
关键词:
摘要: Background Perioperative chemotherapy improves survival in patients with advanced esophagogastric cancer, but the optimal treatment regimen remains unclear. More intensive may improve outcome, also increase toxicity and complications.